达萨替尼对氧化应激和新血管化的作用
Hakan Yildirim1, Mehmet Balbaba1, Mehmet Canleblebici1,2
1Faculty of Medicine, Department of Ophthalmology, Firat University, Elazig, Türkiye.
局部用达沙替尼 2.5 mg/ dL有效降低角膜新血管化,类似于贝瓦西祖马布. 较高的达沙替尼剂量增加了氧化应激和新血管化,表明剂量依赖的效果.
科学领域:
- 眼科 眼科
- 药理学
- 生物化学
背景情况:
- 角膜新血管化 (CNV) 是一种病理过程.
- 氧化应激在CNV中起作用.
- 针对血管内皮生长因子 (VEGF) 途径是一种常见的治疗策略.
研究的目的:
- 为了比较局部贝瓦西祖马布和达沙替尼用于实验性CNV的治疗.
- 评估它们对氧化应激标志物的影响.
- 确定达沙替尼的最佳有效剂量.
主要方法:
- 42只老鼠经历了角膜烧伤.
- 这些组接受了局部贝瓦西祖马布,达沙替尼 (2.5,5或10 mg/ dL) 或载体.
- 分析了新血管化和氧化应激标志物 (VEGF,PDGF,SOD,MDA,PC).
主要成果:
- 与对照组相比,贝瓦西祖马布和达沙替尼 (2. 5 和 5 mg/ dL) 显著降低了VEGF水平.
- 达萨提尼布在2.5mg/ dL的剂量中显示出与贝瓦西祖马布可比的疗效.
- 较高的达沙替尼剂量 (10 mg/ dL) 增加了MDA水平,表明氧化应激增加.
结论:
- 局部大沙替尼在2.5mg/dL的剂量是有效的减少实验CNV.
- 达萨替尼的效果似乎取决于剂量,更高的剂量可能会加剧氧化应激.
- 达萨替尼是一种潜在的治疗药物.
更多相关视频
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
04:17Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies
Published on: June 30, 2023
相关概念视频
Regulation of Angiogenesis and Blood Supply
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen Transport in the Blood
